Fund comparison · from official SEC filings

PRHSX vs VGHCX: how much do they overlap?

T. Rowe Price Health Sciences Fund, Inc. and VANGUARD HEALTH CARE FUND
Holdings overlap
49%
of assets, by weight
Shared positions
48
of 287 / 98 holdings
PRHSX expense ratio
0.83%
net, per year
VGHCX expense ratio
0.33%
net, per year
Shared holdings
Company
PRHSX
VGHCX
L
LLYELI LILLY & CO
10.14%
9.11%
M
MRKMERCK & CO. INC.
3.44%
5.43%
A
AZNASTRAZENECA PLC
3.17%
5.11%
T
TMOTHERMO FISHER SCIENTIFIC INC
4.07%
0.97%
U
UNHUNITEDHEALTH GROUP INC
3.09%
3.93%
I
ISRGINTUITIVE SURGICAL INC
3.65%
2.72%
S
SYKSTRYKER CORP
3.46%
0.83%
J
JNJJOHNSON & JOHNSON
2.44%
3.46%
E
EWEDWARDS LIFESCIENCES CORP
0.41%
3.22%
A
ABBVABBVIE INC
2.84%
1.35%
R
REGNREGENERON PHARMACEUTICALS
2.65%
1.79%
V
VRTXVERTEX PHARMACEUTICALS INC
2.43%
2.10%
B
BSXBOSTON SCIENTIFIC CORP
0.92%
2.36%
D
DHRDANAHER CORP
2.05%
2.35%
C
CVSCVS HEALTH CORP
0.86%
2.21%
C
CORCENCORA INC
0.52%
2.08%
E
ELVELEVANCE HEALTH INC
0.66%
1.90%
A
ALNYALNYLAM PHARMACEUTICALS INC
1.62%
1.41%
H
HCAHCA HEALTHCARE INC
0.90%
1.42%
R
RVMDREVOLUTION MEDICINES INC
1.36%
0.72%
U
UTHRUNITED THERAPEUTICS CORP
1.34%
1.28%
C
CHGCFCHUGAI PHARMACEUTICAL CO LTD
0.58%
1.25%
C
CAHCARDINAL HEALTH INC
0.68%
1.22%
P
PTGXPROTAGONIST THERAPEUTICS INC
1.11%
0.37%
N
NTRANATERA INC
1.03%
0.26%
Only in PRHSX
A
ARGXARGENX SE - ADR
2.92%
G
GILDGILEAD SCIENCES INC
2.60%
?
ASCENDIS PHARMA A/S - ADR
1.42%
B
BEIGFBEONE MEDICINES LTD-H
1.19%
R
ROIVROIVANT SCIENCES LTD
1.13%
I
INSMINSMED INC
1.06%
S
SMMTSUMMIT THERAPEUTICS INC
1.04%
T
THCTENET HEALTHCARE CORP
1.01%
B
BTSGBRIGHTSPRING HEALTH SERVICES
0.98%
A
AMGNAMGEN INC
0.98%
G
GHGUARDANT HEALTH INC
0.90%
C
CITHE CIGNA GROUP
0.74%
K
KRYSKRYSTAL BIOTECH INC
0.65%
P
PRAXPRAXIS PRECISION MEDICINES I
0.56%
C
CELCCELCUITY INC
0.56%
R
RPRXROYALTY PHARMA PLC- CL A
0.55%
2
260CENTESSA PHARMACEUTICALS-ADR
0.50%
V
VERAVERA THERAPEUTICS INC
0.46%
5
5AXNUVALENT INC-A
0.43%
A
ABVXABIVAX SA-ADR
0.42%
S
SYRESPYRE THERAPEUTICS INC
0.40%
T
TENXTENAX THERAPEUTICS INC
0.36%
T
TRPGRIAT ROWE PR GOVT RSRV INV FND
0.35%
I
IQVIQVIA HOLDINGS INC
0.33%
K
KODKODIAK SCIENCES INC
0.32%
Only in VGHCX
G
GLAXFGSK PLC
3.14%
A
ARGNFARGENX SE
2.21%
A
ABTABBOTT LABORATORIES
2.18%
U
UCBJFUCB SA
1.74%
N
NVSEFNOVARTIS AG-REG
1.63%
B
BIIBBIOGEN INC
1.30%
G
GDERFGALDERMA GROUP AG
1.27%
R
RHHVFROCHE HOLDING AG
1.24%
O
OTSKFOTSUKA HOLDINGS CO LTD
1.23%
A
AAGILENT TECHNOLOGIES INC
1.20%
S
SGIOFSHIONOGI & CO LTD
1.12%
D
DXCMDEXCOM INC
1.03%
D
DSKYFDAIICHI SANKYO CO LTD
1.00%
G
GNMSFGENMAB A/S
0.97%
M
MDTMEDTRONIC PLC
0.93%
A
ASNDASCENDIS PHARMA A/S
0.66%
S
STESTERIS PLC
0.64%
Q
QGENQIAGEN N.V.
0.61%
B
BMYBRISTOL-MYERS SQUIBB CO
0.60%
E
ESALFEISAI CO LTD
0.60%
I
ICLRICON PLC
0.50%
N
NONOFNOVO NORDISK A/S-B
0.48%
H
HTFLHEARTFLOW INC
0.46%
A
AVTRAVANTOR INC
0.45%
X
XENEXENON PHARMACEUTICALS INC
0.41%
Hold PRHSX and VGHCX together? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Data source: official SEC Form N-PORT filings from each fund. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.